TCI Wealth Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
TCI Wealth Advisors's MDGL Position: Q3 2026 in Review
TCI Wealth Advisors held its Madrigal Pharmaceuticals (MDGL) position steady in Q3 2026 at 517 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #233.
TCI Wealth Advisors first reported a position in MDGL in Q4 2018 and has held it in 12 quarters since. The position peaked at $301K in Q4 2025. 440 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- TCI Wealth Advisors held 517 shares of Madrigal Pharmaceuticals worth $261K as of Q3 2026.
- TCI Wealth Advisors left its Madrigal Pharmaceuticals share count unchanged in Q3 2026.
- Madrigal Pharmaceuticals made up 0.01% of TCI Wealth Advisors's portfolio in Q3 2026, its #233 holding.
- TCI Wealth Advisors first reported a position in Madrigal Pharmaceuticals in Q4 2018 and has held it in 12 quarters since.
- TCI Wealth Advisors's Madrigal Pharmaceuticals position peaked at $301K in Q4 2025.
- 440 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on TCI Wealth Advisors's 13F filing for Q3 2026, filed 30 Oct 2026.